Skip to main content
. Author manuscript; available in PMC: 2021 Apr 5.
Published in final edited form as: Clin Cancer Res. 2019 Apr 19;25(14):4264–4270. doi: 10.1158/1078-0432.CCR-19-0361

Figure 1.

Figure 1.

Receiver-operating characteristic curve of sensitivity vs. 1–specificity for a multivariate model including TLS risk group (low, medium, high) and creatinine clearance (< 80 mL/min vs ≥ 80 mL/min). The area under the ROC curve is 79.6%